Filana Therapeutics, Inc. · NASDAQ:FLNA
Filana Therapeutics, Inc. shareholders
As of Jun 30, 2026, 81 institutions reported holding Filana Therapeutics, Inc., 26.2% of its shares. Largest: Vanguard, Two Sigma and Marshall Wace, LLP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Filana Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 2.45M | 5.1% | +84,067 | Aug 13, 2026 |
| Two Sigma | 1.71M | 3.5% | −277K | Aug 14, 2026 |
| Marshall Wace, LLP | 1.6M | 3.3% | −415K | Aug 13, 2026 |
| BlackRock | 1.45M | 3.0% | +39,047 | Aug 7, 2026 |
| Goldman Sachs | 669K | 1.4% | +627K | Aug 14, 2026 |
| Geode Capital | 616K | 1.3% | +19,268 | Aug 12, 2026 |
| D. E. Shaw & Co., Inc. | 485K | 1.0% | −74,180 | Aug 14, 2026 |
| GMT Capital Corp | 450K | 0.93% | no change | Aug 14, 2026 |
| Renaissance Technologies | 390K | 0.81% | +62,842 | Aug 13, 2026 |
| Squarepoint Ops LLC | 318K | 0.66% | new | Aug 14, 2026 |